Rol del ambiente en las enfermedades inflamatorias intestinales

1. Uhlig HH, Schwerd T, Koletzko S, et al; COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990-1007.e3.

2. Jostins L, Ripke S,Weersma RK, et al; International IBD Genetics Consortium (IIBDGC).

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-124.

3. McGovern DP, Kugathasan S, Cho JH. Genetics of inflammatory bowel diseases. Gastroenterology. 2015;149(5):1163-1176.e2.

4. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307-317.

5. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the

inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54.e42.

6. Ng SC, TangW, Ching JY, et al; Asia–Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158-165.e2.

7. Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease

incidence study in mainland of China: the emergence of “western” disease. Inflamm Bowel Dis.

2013;19(9):1839-1845.

8. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM.

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423-439.

9. Malmborg P, Grahnquist L, Lindholm J, Montgomery S, Hildebrand H. Increasing incidence

of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007. J Pediatr

Gastroenterol Nutr. 2013;57(1):29-34.

10. Hope B, Shahdadpuri R, Dunne C, et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child. 2012;97(7):590-594.

11. Martin-de-Carpi J, Rodriguez A, Ramos E, Jimenez S, Martinez-Gomez MJ, Medina E;

SPIRIT-IBD Working Group of Sociedad Española de Gastroenterología, Hepatología y Nutrición

Pediátrica. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009)

the SPIRIT Registry. Inflamm Bowel Dis. 2013;19(1):73-80.

12. Jakobsen C, Paerregaard A, Munkholm P, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective

population-based cohort study 2007-2009. Inflamm Bowel Dis. 2011;17(12):2541-2550.

13. Martin-de-Carpi J, Rodriguez A, Ramos E, et al; SPIRIT-IBD Working Group of SEGHNP (Sociedad Española de Gastroenterología Hepatología Nutrición Pediátrica). The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry. J Crohn s Colitis. 2014;8(8): 763-769.

14. Bequet E, Sarter H, Fumery M, et al; EPIMAD Group. Incidence and phenotype at diagnosis of very-early-onset compared with late-onset paediatric inflammatory bowel disease: a population-based study [1988-2011]. J Crohns Colitis. 2016;jjw194.

15. Henderson P, Hansen R, Cameron FL, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis. 2012;18(6):999-1005.

16. Benchimol EI, Bernstein CN, Bitton A, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017.

17. Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr. 2010;50(1):27-31.

18. Wild CP. The exposure: from concept to utility. Int J Epidemiol. 2012;41(1):24-32.

19. Anaya JM, Ramírez-Santana C, Alzate MA, Molano-Gonzalez N, Rojas-Villarraga A. The

autoimmune ecology. Front Immunol. 2016;7:139.

20. Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2):327-339.e4.

21. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset

Crohn’s disease. Cell Host Microbe. 2014;15(3):382-392.

22. Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric crohn’s disease. Cell Host Microbe. 2015;18 (4):489-500.

23. Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):

1039-1048.

24. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160(3): 447-460.

25. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One. 2013;8(3):e59260.

26. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr. 1999;28(1):19-25.

27. Salminen S, Gibson GR,McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004;53(9):1388-1389.

28. Bager P, Simonsen J, Nielsen NM, Frisch M. Cesarean section and offspring’s risk of

inflammatory bowel disease: a national cohort study. Inflamm Bowel Dis. 2012;18(5):857-862.

29. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group.

Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis. 2010;16(5):847-855.

30. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic

review: the role of breastfeeding in the development of pediatric inflammatory bowel

disease. J Pediatr. 2009;155(3):421-426.

31. Ng SC, TangW, Leong RW, et al; Asia-Pacific Crohn’s and Colitis Epidemiology Study ACCESS Group. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64(7):1063-1071.

32. Ko Y, Kariyawasam V, Karnib M, et al; IBD Sydney Organisation. Inflammatory bowel disease environmental risk factors: a population-based case-control study of middle eastern migration to australia. Clin Gastroenterol Hepatol. 2015;13(8):1453-63.e1.

33. Cholapranee A, Ananthakrishnan AN. Environmental hygiene and risk of inflammatory

bowel diseases: a systematic review and meta-analysis. Inflamm Bowel Dis. 2016;22(9):

2191-2199.

34. Chu KM, Watermeyer G, Shelly L, et al. Childhood helminth exposure is protective against

inflammatory bowel disease: a case control study in South Africa. Inflamm Bowel Dis. 2013;19(3):614-620.

35. Bager P, Vinkel Hansen A,Wohlfahrt J, Melbye M. Helminth infection does not reduce

risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology.

2012;142(1):55-62.

36. Helmby H. Human helminth therapy to treat inflammatory disorders: where do we stand? BMC Immunol. 2015;16:12.

37. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of

ulcerative colitis and Crohn’s disease. Gut. 2014;63 (5):776-784.

38. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563-573.

39. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53 (10):1479-1484.

40. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145(5):

970-977.

41. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3(10):858-876.

42. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is

associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142(3):482-489.

43. Alhassan Mohammed H, Saboor-Yaraghi AA, Mirshafiey A, Vahedi H, Shiri-ShahsavarMR,

Mousavi Nasl Khameneh A. Immunomodulatory and immunosuppressive roles of 1α,25(OH)2D3 in autoimmune diseases. Scand J Immunol. 2017;85 (2):95-103.

44. Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61(12):1686-1692.

45. Chassaing B, Koren O, Goodrich JK, et al.Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92-96.

46. Ruemmele FM, Veres G, Kolho KL, et al; European Crohn’s and Colitis Organisation;    European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014;8 (10):1179-1207.